DocGo Inc. Operating Expenses
DocGo Inc. (DCGO) reported Operating Expenses of $91.35 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-17
- DocGo Inc. operating expenses for the quarter ending 2026-06-30 was $91.35M, a 6.69% decline year-over-year.
- DocGo Inc. operating expenses for the quarter ending 2026-03-31 was $94.26M, a 14.33% decline year-over-year.
- DocGo Inc. operating expenses for the quarter ending 2025-12-31 was $179.52M, a 39.91% increase year-over-year.
- DocGo Inc. operating expenses for the quarter ending 2025-09-30 was $112.79M, a 12.26% decline year-over-year.
- DocGo Inc. operating expenses for fiscal 2025 was $500.23M, a 14.91% decline from fiscal 2024.
- DocGo Inc. operating expenses for fiscal 2024 was $587.87M, a 3.51% decline from fiscal 2023.
- DocGo Inc. operating expenses for fiscal 2023 was $609.23M, a 45.51% increase from fiscal 2022.
- DocGo Inc. operating expenses for fiscal 2022 was $418.68M, a 38.02% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $91.35M 10-Q · filed 2026-08-17 | $185.61M 10-Q · filed 2026-08-17 | $365.12M derived: sum of 3 quarters · filed 2026-08-17 | $477.91M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $94.26M 10-Q · filed 2026-05-11 | $273.78M derived: sum of 2 quarters · filed 2026-05-11 | $386.56M derived: sum of 3 quarters · filed 2026-05-11 | $484.46M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $179.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $292.30M derived: sum of 2 quarters · filed 2026-03-16 | $390.20M derived: sum of 3 quarters · filed 2026-08-17 | $500.23M 10-K · filed 2026-03-16 |
| 2025-09-30 | $112.79M 10-Q · filed 2025-11-10 | $210.68M derived: sum of 2 quarters · filed 2026-08-17 | $320.71M 10-Q · filed 2025-11-10 | $449.02M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $97.90M 10-Q · filed 2026-08-17 | $207.93M 10-Q · filed 2026-08-17 | $336.23M derived: sum of 3 quarters · filed 2026-08-17 | $464.78M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $110.03M 10-Q · filed 2026-05-11 | $238.34M derived: sum of 2 quarters · filed 2026-05-11 | $366.88M derived: sum of 3 quarters · filed 2026-05-11 | $521.68M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $128.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $256.85M derived: sum of 2 quarters · filed 2026-03-16 | $411.65M derived: sum of 3 quarters · filed 2026-03-16 | $587.87M 10-K · filed 2026-03-16 |
| 2024-09-30 | $128.55M 10-Q · filed 2025-11-10 | $283.35M derived: sum of 2 quarters · filed 2025-11-10 | $459.56M 10-Q · filed 2025-11-10 | $647.13M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | $154.80M 10-Q · filed 2025-08-07 | $331.01M 10-Q · filed 2025-08-07 | $518.59M derived: sum of 3 quarters · filed 2026-03-16 | $696.43M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | $176.21M 10-Q · filed 2025-05-08 | $363.78M derived: sum of 2 quarters · filed 2026-03-16 | $541.63M derived: sum of 3 quarters · filed 2026-03-16 | $665.54M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $187.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $365.42M derived: sum of 2 quarters · filed 2026-03-16 | $489.33M derived: sum of 3 quarters · filed 2026-03-16 | $609.23M 10-K · filed 2026-03-16 |
| 2023-09-30 | $177.84M 10-Q · filed 2024-11-07 | $301.76M derived: sum of 2 quarters · filed 2024-11-07 | $421.66M 10-Q · filed 2024-11-07 | $530.37M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $123.91M 10-Q · filed 2024-08-07 | $243.82M 10-Q · filed 2024-08-07 | $352.52M derived: sum of 3 quarters · filed 2025-02-27 | $452.64M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $119.91M 10-Q · filed 2024-05-08 | $228.61M derived: sum of 2 quarters · filed 2025-02-27 | $328.73M derived: sum of 3 quarters · filed 2025-02-27 | $430.79M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $108.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $208.83M derived: sum of 2 quarters · filed 2025-02-27 | $310.89M derived: sum of 3 quarters · filed 2025-02-27 | $418.68M 10-K · filed 2025-02-27 |
| 2022-09-30 | $100.12M 10-Q · filed 2023-11-06 | $202.18M derived: sum of 2 quarters · filed 2023-11-06 | $309.98M 10-Q · filed 2023-11-06 | $415.85M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $102.06M 10-Q · filed 2023-08-08 | $209.86M 10-Q · filed 2023-08-08 | $315.73M derived: sum of 3 quarters · filed 2024-02-28 | $400.05M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $107.80M 10-Q · filed 2023-05-09 | $213.67M derived: sum of 2 quarters · filed 2024-02-28 | $297.99M derived: sum of 3 quarters · filed 2024-02-28 | $359.91M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $105.87M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $190.19M derived: sum of 2 quarters · filed 2024-02-28 | $252.12M derived: sum of 3 quarters · filed 2024-02-28 | $303.36M 10-K · filed 2024-02-28 |
| 2021-09-30 | $84.32M 10-Q · filed 2022-11-08 | $146.25M derived: sum of 2 quarters · filed 2022-11-08 | $197.49M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $61.93M 10-Q · filed 2022-08-09 | $113.17M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $51.56M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $108.85M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |